The Immuno‐Cardiovascular Storm of Pre‐Eclampsia: Cytokine‐Mediated Endothelial Injury, Thrombosis, and Maternal Cardiovascular Instability
Comprehensive Physiology · 2026
DOI: 10.1002/cph4.70209 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, 2026. Verfasst von Emmanuel Ifeanyi Obeagu. Beteiligte Einrichtung: Division of Haematology, Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe. Hauptthemen laut MEDLINE: Pre-Eclampsia, Cytokines, Endothelium, Vascular, Thrombosis. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pre‐eclampsia is a complex multisystem hypertensive disorder of pregnancy and a leading cause of maternal and perinatal morbidity and mortality worldwide. Increasing evidence suggests that the condition extends beyond abnormal placentation and represents an integrated immuno‐cardiovascular disorder characterized by immune dysregulation, endothelial dysfunction, thromboinflammation, and cardiovascular maladaptation. This narrative review examines the interconnected mechanisms linking cytokine‐mediated inflammation, endothelial injury, coagulation abnormalities, and maternal cardiovascular instability in pre‐eclampsia. A structured literature search of major biomedical databases was conducted to identify relevant experimental, clinical, and translational studies addressing inflammatory cytokines, angiogenic imbalance, endothelial dysfunction, thrombosis, biomarkers, and therapeutic strategies in pre‐eclampsia. The review highlights the central roles of pro‐inflammatory mediators, including tumor necrosis factor‐α, interleukin‐6, interleukin‐17, and interferon‐γ, in promoting oxidative stress, vascular inflammation, and endothelial dysfunction. Particular attention is given to the development of an immunothrombotic environment, defined as the pathological interaction between immune activation and coagulation pathways that promotes thrombosis and vascular injury. The review also critically evaluates the contribution of antiangiogenic factors, platelet activation, impaired fibrinolysis, and cardiovascular remodeling to maternal disease progression. In addition, current and emerging therapeutic approaches targeting inflammatory, endothelial, angiogenic, and thrombotic pathways are discussed, together with their translational potential and clinical limitations. By integrating immunological, vascular, hematological, and cardiovascular perspectives, this review provides a comprehensive framework for understanding the pathophysiology of pre‐eclampsia and identifies important knowledge gaps for future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Haematology, Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
- Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Emmanuel Ifeanyi Obeagu
Zitieren
APA
Obeagu, E. I. (2026). The Immuno‐Cardiovascular Storm of Pre‐Eclampsia: Cytokine‐Mediated Endothelial Injury, Thrombosis, and Maternal Cardiovascular Instability. Comprehensive Physiology. https://doi.org/10.1002/cph4.70209
Vancouver
Obeagu EI. The Immuno‐Cardiovascular Storm of Pre‐Eclampsia: Cytokine‐Mediated Endothelial Injury, Thrombosis, and Maternal Cardiovascular Instability. Comprehensive Physiology. 2026. doi:10.1002/cph4.70209
BibTeX
@article{Obeagu2026,
author = {Obeagu, Emmanuel Ifeanyi},
title = {The Immuno‐Cardiovascular Storm of Pre‐Eclampsia: Cytokine‐Mediated Endothelial Injury, Thrombosis, and Maternal Cardiovascular Instability},
journal = {Comprehensive Physiology},
year = {2026},
doi = {10.1002/cph4.70209}
}
EUVIMED